Literature DB >> 29892485

Re: Repair of pan-urethral stricture: Proximal ventral and distal dorsal onlay technique of buccal mucosal graft urethroplasty. By Subbarao Chodisetti, Yogesh Boddepalli, Malakondareddy Kota.

Ahmed M Harraz1,2.   

Abstract

Entities:  

Year:  2018        PMID: 29892485      PMCID: PMC5992256          DOI: 10.1016/j.aju.2018.04.001

Source DB:  PubMed          Journal:  Arab J Urol        ISSN: 2090-598X


× No keyword cloud information.
The authors have described their technique for managing panurethral strictures by applying buccal mucosal graft (BMG) dorsally and ventrally in the distal and proximal portions of the stricture, respectively. The merit of this approach, from our perspective, is that it could handle extremely proximal strictures, as these strictures are deeply seated in the pelvis and the ventral approach is more technically feasible in this situation. Nevertheless, two main points should be considered. First, the authors have used two separate incisions to approach the entire anterior urethra, and this could have been avoided by using the penile invagination technique described by Kulkarni et al. [1], and hence, minimising patient morbidity. Second, the use of a single dorsal incision is technically feasible even in proximal urethral strictures and has proven effectiveness [2]. To summarise, although the described approach is potentially feasible, the single dorsal incision with penile invagination should be considered as well.

Conflict of interest

None.
  2 in total

Review 1.  Management of Panurethral Stricture.

Authors:  Sanjay Kulkarni; Jyotsna Kulkarni; Sandesh Surana; Pankaj M Joshi
Journal:  Urol Clin North Am       Date:  2017-02       Impact factor: 2.241

2.  Clinical and Patient-reported Outcomes of 1-sided Anterior Urethroplasty for Long-segment or Panurethral Strictures.

Authors:  Jeffrey Spencer; Stephen Blakely; Michael Daugherty; Javier C Angulo; Francisco Martins; Krishnan Venkatesan; Dmitriy Nikolavsky
Journal:  Urology       Date:  2017-08-30       Impact factor: 2.649

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.